Investors

For a comprehensive breakdown of all investment particulars, please download our Investor Deck.

Critical Path

  • 1

    CTA Approval

    APEX has an approved CTA with Health Canada by way of an NOL for both a phase 2a and phase 2b clinical trial using APEX-002 and APEX-52 GMP drug products.

  • 2

    Product Sourcing

    APEX has purchased GMP API psilocybin which has been formulated, labelled and bottled to supply the clinical pipeline and early access program.

  • 3

    Launch

    APEX will launch multiple clinical trials with Veterans in Canada, US and Internationally. APEX has assembled a clinical team that has successfully conducted both phase 2 and phase 3 clinical trials with psychedelic compounds.

* Directive on Physical Security Requirements for Controlled Substances and Drugs Containing Cannabis

Revenue Model

  • 1
  • 2
  • 3
  • 4
  • SAP Micro

    Pricing model exercise for take home micro-dose product with physician oversight with pre and post integration work.

  • SAP Macro

    In clinic macro-dose with assisted psychotherapy through strategic partnerships with Veteran focused clinics with nation-wide footprints.

  • Pre-DIN

    Pre-DIN (Drug Identification Number) revenue created by insurance coverage for Veterans and retired RCMP Officers.

  • DIN

    Secure DIN via strategic, phased clinical program seeking regulatory approval from bodies like Health Canada and the FDA.

1

SAP Micro

Pricing model exercise for take home micro-dose product with physician oversight with pre and post integration work.

2

SAP Macro

In clinic macro-dose with assisted psychotherapy through strategic partnerships with Veteran focused clinics with nation-wide footprints.

3

Pre-DIN

Pre-DIN (Drug Identification Number) revenue created by insurance coverage for Veterans and retired RCMP Officers.

4

DIN

Secure DIN via strategic, phased clinical program seeking regulatory approval from bodies like Health Canada and the FDA.